Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')
about
Visual hallucinatory syndromes: past, present, and futureThe pharmacology and toxicology of "ecstasy" (MDMA) and related drugsCharacteristics of ecstasy users in Sãio Paulo, Brazil.Cognitive vision, its disorders and differential diagnosis in adults and children: knowing where and what things are.Ecstasy: are animal data consistent between species and can they translate to humans?Typology of club drug use among young adults recruited using time-space sampling.A pure amnestic syndrome after MDMA ("ecstasy") ingestion.Management of drug abuse emergencies."Saturday night fever": ecstasy related problems in a London accident and emergency department.A comprehensive review of MDMA and GHB: two common club drugs.Ecstasy: dangers and controversies.Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.Evidence-based treatment for Depersonalisation-derealisation Disorder (DPRD).Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history.Acute psychological and neurophysiological effects of MDMA in humans.Prevalence and childhood antecedents of depersonalization syndrome in a UK birth cohortTri-city study of Ecstasy use problems: a latent class analysis.High rates of club drug use and risky sexual practices among Hispanic men who have sex with men in Miami, Florida.Palinopsia from a posteriorly placed glioma--an insight into its possible causes.Ecstasy intoxication: the toxicological basis for treatment.Symptomatological features of patients with and without Ecstasy use during their first psychotic episode.Ecstasy and neurodegeneration.Ecstasy and neurodegeneration. No evidence of neurotoxicity exists.Ecstasy and neurodegeneration. Tablets often contain substances in addition to, or instead of, ecstasy...An "accidental" acute psychosis with ecstasy use.Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms.Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention.The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users.Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse.The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use.Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria.Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.From “Male Bonding Rituals” to “Suicide Tuesday”
P2860
Q24635621-64365CFB-91C4-44C8-A804-3C5F3DA6367BQ28361466-934A3E8D-9155-4842-8E64-270BCA787B8AQ30350392-D890DDC0-1F15-4FB7-AF2D-5E7101DB8AD2Q30922926-670D2F5D-0F75-4E64-9D7A-92B93D4799CFQ31033315-97128561-F97D-48B5-8328-BF09F4822374Q33653346-549425F2-122C-4B35-9256-3169F19F7ABEQ33735755-A4A8CB3B-0B82-4769-99A9-AC5A533899B9Q34291877-1F93B2F5-5596-47CF-BF41-DF5A6FF5F733Q34292882-87909C30-D05A-4C67-8A79-E47B823C8AEAQ34476901-EFF58C65-BBBF-4847-A413-B0848B9A53C2Q34476926-D4D0C26C-F3AB-4187-83AA-31879FF549B5Q34569376-F69BA2BE-E736-4ED0-8F5E-92BB22F037ADQ34728943-D46953D0-B8D1-4970-B9CE-A09CE9C0120BQ34982526-3DA37CE2-DD6E-46D9-8C75-E1BADB3150EBQ35105559-D5379DE7-31B5-4669-AE57-0EBAED40028DQ35969233-E115EBCA-F28F-495C-9BF1-53744760FFE8Q37071511-9A512EDE-C222-4933-94BD-53FFEAC70E26Q39725000-AAAEB8C7-87AF-4EF3-B2E3-D77858D66402Q39799851-E9E6420D-C8E8-4E37-961A-9733423CEEC5Q40540791-3AB4A2FA-2784-422D-B80A-D67A795B4035Q42254623-D98F76F8-682C-4C1F-AA84-7862926E3571Q43090371-22D1EDAB-E10B-4657-9FF6-1DA797CE8CC6Q43189199-31EBDF5A-CBFF-40EE-8474-5250D83CB985Q43189245-8B3171BF-7429-4DA9-8A8A-BC4F9A16C7FAQ43595265-7E41E36C-F040-479A-8F6C-E7B6160FB860Q43743722-5D269FE4-2655-474D-89D4-911CEE37B09FQ44359164-DA077DBC-119B-4CCF-9872-D5C2C21855F5Q45059993-724AB8AB-9F84-49B2-AF51-9D98256E105EQ47151284-3FCD99C0-3DB1-4CC3-9BC7-8DC0A62147C6Q48381656-6C38AC98-9674-4F14-B0CC-11B947CC5F0AQ51899385-71AE57FB-F8B2-40BD-8D77-B8E163462F1DQ51971591-82BEC78B-1B12-47E7-86D6-9A4711EACB3FQ52009759-872760A1-8B38-40C8-BFC8-028C0566C903Q54296991-9A914F84-3F1A-4EAA-AF54-D3EDCECF56B4Q54297002-893E1E77-D848-4727-9635-91AC2333BC5FQ58346702-B5A27EF2-206A-4A68-9776-83B753323045
P2860
Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Diversity of psychopathology a ...... oxymethamphetamine ('Ecstasy')
@ast
Diversity of psychopathology a ...... oxymethamphetamine ('Ecstasy')
@en
Diversity of psychopathology a ...... oxymethamphetamine ('Ecstasy')
@nl
type
label
Diversity of psychopathology a ...... oxymethamphetamine ('Ecstasy')
@ast
Diversity of psychopathology a ...... oxymethamphetamine ('Ecstasy')
@en
Diversity of psychopathology a ...... oxymethamphetamine ('Ecstasy')
@nl
prefLabel
Diversity of psychopathology a ...... oxymethamphetamine ('Ecstasy')
@ast
Diversity of psychopathology a ...... oxymethamphetamine ('Ecstasy')
@en
Diversity of psychopathology a ...... oxymethamphetamine ('Ecstasy')
@nl
P2093
P356
P1476
Diversity of psychopathology a ...... oxymethamphetamine ('Ecstasy')
@en
P2093
P304
P356
10.1192/BJP.165.3.391
P407
P577
1994-09-01T00:00:00Z